179 related articles for article (PubMed ID: 24301904)
21. Affective symptoms and cognitive functions in Parkinson's disease.
Poletti M; De Rosa A; Bonuccelli U
J Neurol Sci; 2012 Jun; 317(1-2):97-102. PubMed ID: 22503136
[TBL] [Abstract][Full Text] [Related]
22. Loss of libido in Parkinson's disease.
Kummer A; Cardoso F; Teixeira AL
J Sex Med; 2009 Apr; 6(4):1024-1031. PubMed ID: 19040621
[TBL] [Abstract][Full Text] [Related]
23. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
Hoogland J; de Bie RM; Williams-Gray CH; Muslimović D; Schmand B; Post B
Mov Disord; 2010 Nov; 25(15):2550-4. PubMed ID: 20878993
[TBL] [Abstract][Full Text] [Related]
24. A holistic analysis of relationships between executive function and memory in Parkinson's disease.
Alonso Recio L; Martín P; Carvajal F; Ruiz M; Serrano JM
J Clin Exp Neuropsychol; 2013; 35(2):147-59. PubMed ID: 23289666
[TBL] [Abstract][Full Text] [Related]
25. "DASH" symptoms in patients with Parkinson's disease: red flags for early cognitive decline.
Naismith SL; Lewis SJ
J Clin Neurosci; 2011 Mar; 18(3):352-5. PubMed ID: 21237647
[TBL] [Abstract][Full Text] [Related]
26. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
Ojagbemi A
J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
[TBL] [Abstract][Full Text] [Related]
27. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
[TBL] [Abstract][Full Text] [Related]
28. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
29. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
[TBL] [Abstract][Full Text] [Related]
30. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.
Nie K; Zhang Y; Wang L; Zhao J; Huang Z; Gan R; Li S; Wang L
J Clin Neurosci; 2012 Nov; 19(11):1497-500. PubMed ID: 22959678
[TBL] [Abstract][Full Text] [Related]
31. [Study on the status of cognition among Parkinson's disease patients in Xi'an.].
Wang RL; Qu QM; Cao HM; Zhe X; Qiao J; Guo F
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):329-32. PubMed ID: 20510065
[TBL] [Abstract][Full Text] [Related]
32. Sleep correlates of trait executive function and memory in Parkinson's disease.
Scullin MK; Fairley JA; Trotti LM; Goldstein FC; Factor SA; Bliwise DL
J Parkinsons Dis; 2015; 5(1):49-54. PubMed ID: 25588355
[TBL] [Abstract][Full Text] [Related]
33. Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease.
Cohen OS; Vakil E; Tanne D; Nitsan Z; Schwartz R; Hassin-Baer S
Cogn Behav Neurol; 2007 Mar; 20(1):68-72. PubMed ID: 17356347
[TBL] [Abstract][Full Text] [Related]
34. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
Kulisevsky J; Pagonabarraga J
Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
[TBL] [Abstract][Full Text] [Related]
35. Combination of plasma tumor necrosis factor receptors signaling proteins, beta-amyloid and apolipoprotein E for the detection of Alzheimer's disease.
Zhang J; Jia J; Qin W; Wang S
Neurosci Lett; 2013 Apr; 541():99-104. PubMed ID: 23500026
[TBL] [Abstract][Full Text] [Related]
36. [The frontal assessment battery at bed side(FAB) in patients with Parkinson's disease].
Takagi R; Kajimoto Y; Kamiyoshi S; Miwa H; Kondo T
No To Shinkei; 2002 Oct; 54(10):897-902. PubMed ID: 12476579
[TBL] [Abstract][Full Text] [Related]
37. Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.
Narme P; Mouras H; Roussel M; Duru C; Krystkowiak P; Godefroy O
Neuropsychology; 2013 Mar; 27(2):182-92. PubMed ID: 23527646
[TBL] [Abstract][Full Text] [Related]
38. Subjective and objective assessment of executive functions in Parkinson's disease.
Koerts J; Tucha L; Leenders KL; van Beilen M; Brouwer WH; Tucha O
J Neurol Sci; 2011 Nov; 310(1-2):172-5. PubMed ID: 21807381
[TBL] [Abstract][Full Text] [Related]
39. Autonomic and cognitive functions in Parkinson's disease (PD).
Oh ES; Lee JH; Seo JG; Sohn EH; Lee AY
Arch Gerontol Geriatr; 2011; 52(1):84-8. PubMed ID: 20223528
[TBL] [Abstract][Full Text] [Related]
40. Apathy in Parkinson's disease: more than just executive dysfunction.
Martínez-Horta S; Pagonabarraga J; Fernández de Bobadilla R; García-Sanchez C; Kulisevsky J
J Int Neuropsychol Soc; 2013 May; 19(5):571-82. PubMed ID: 23425620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
